TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Return on Equity [ROE] (2021 - 2026)

Updated

TScan Therapeutics (TCRX) posted Return on Equity [ROE] of -215.06% for Q3 2026, down 126.14 percentage points from -88.92% a year earlier and down 73.19 percentage points from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, TScan Therapeutics' Return on Equity [ROE] came in at -71.31%, down 6.26 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a four-year change of +10.89 percentage points (FY2021 to FY2025).
  • In prior years, TScan Therapeutics' Return on Equity [ROE] was -65.05% in FY2024 (+6.24 pp), -71.29% in FY2023 (-20.39 pp), -50.90% in FY2022 (+31.30 pp) and -82.20% in FY2021.
  • The Q3 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q3 2021.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last six quarters, with an average year-over-year change of -42.43 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2022, with a gain of 24.37 percentage points; the weakest was Q3 2026, with a drop of 126.14 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -141.87% (Q2 2026), -112.98% (Q1 2026) and -97.19% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -1,456.09%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 74.39%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 19.33%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 5.63%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -31.17%
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -215.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -215.06%
Jun 30, 2026 -141.87%
Mar 31, 2026 -112.98%
Dec 31, 2025 -97.19%
Sep 30, 2025 -88.92%
Jun 30, 2025 -70.70%
Mar 31, 2025 -58.29%
Dec 31, 2024 -54.23%
Sep 30, 2024 -45.96%
Jun 30, 2024 -55.22%
Mar 31, 2024 -70.70%
Dec 31, 2023 -55.79%
Sep 30, 2023 -49.13%
Jun 30, 2023 -60.74%
Mar 31, 2023 -81.86%
Dec 31, 2022 -61.29%
Sep 30, 2022 -49.69%
Jun 30, 2022 -44.20%
Mar 31, 2022 -37.11%
Dec 31, 2021 -29.04%
API Access

TScan Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TCRX&period=max&api_key=YOUR_API_KEY